Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Bengsch

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Hepatology (Baltimore, Md.)|March 21, 2022
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world studyAntonio D'Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, et al.
Nature|April 12, 2017
T-cell invigoration to tumour burden ratio associated with anti-PD-1 responseAlexander C Huang, Michael A Postow, Robert J Orlowski, et al.
Science Immunology|February 6, 2026
Single-cell profiling reveals diverse γδ T cell subsets in ulcerative colitisLena S Mayer, Jakob Arnold, Felix Roettele, et al.
Journal for Immunotherapy of Cancer|October 6, 2025
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumabBernhard Scheiner, Pasquale Lombardi, Antonio D'Alessio, et al.
Journal of Human Immunity|May 15, 2026
FAS-controlled T cells drive lymphoproliferation through glycolysis without effector differentiationMaria Elena Maccari, Christoph König, Geoffroy Andrieux, et al.
Nature Medicine|February 27, 2019
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanomaAlexander C Huang, Robert J Orlowski, Xiaowei Xu, et al.
Nature Immunology|February 2, 2023
Phosphoinositide acyl chain saturation drives CD8<sup>+</sup> effector T cell signaling and functionJoy Edwards-Hicks, Petya Apostolova, Joerg M Buescher, et al.
Science Immunology|June 3, 2018
Identification and characterization of HIV-specific resident memory CD8<sup>+</sup> T cells in human lymphoid tissueMarcus Buggert, Son Nguyen, Gonzalo Salgado-Montes de Oca, et al.
The Journal of Experimental Medicine|November 10, 2020
A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FASMaria Elena Maccari, Sebastian Fuchs, Patrick Kury, et al.
Nature|January 25, 2023
Tissue CD14<sup>+</sup>CD8<sup>+</sup> T cells reprogrammed by myeloid cells and modulated by LPSLaura J Pallett, Leo Swadling, Mariana Diniz, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Hepatology (Baltimore, Md.)|March 21, 2022
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world studyAntonio D'Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, et al.
Nature|April 12, 2017
T-cell invigoration to tumour burden ratio associated with anti-PD-1 responseAlexander C Huang, Michael A Postow, Robert J Orlowski, et al.
Science Immunology|February 6, 2026
Single-cell profiling reveals diverse γδ T cell subsets in ulcerative colitisLena S Mayer, Jakob Arnold, Felix Roettele, et al.
Journal for Immunotherapy of Cancer|October 6, 2025
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumabBernhard Scheiner, Pasquale Lombardi, Antonio D'Alessio, et al.
Journal of Human Immunity|May 15, 2026
FAS-controlled T cells drive lymphoproliferation through glycolysis without effector differentiationMaria Elena Maccari, Christoph König, Geoffroy Andrieux, et al.
Nature Medicine|February 27, 2019
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanomaAlexander C Huang, Robert J Orlowski, Xiaowei Xu, et al.
Nature Immunology|February 2, 2023
Phosphoinositide acyl chain saturation drives CD8<sup>+</sup> effector T cell signaling and functionJoy Edwards-Hicks, Petya Apostolova, Joerg M Buescher, et al.
Science Immunology|June 3, 2018
Identification and characterization of HIV-specific resident memory CD8<sup>+</sup> T cells in human lymphoid tissueMarcus Buggert, Son Nguyen, Gonzalo Salgado-Montes de Oca, et al.
The Journal of Experimental Medicine|November 10, 2020
A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FASMaria Elena Maccari, Sebastian Fuchs, Patrick Kury, et al.
Nature|January 25, 2023
Tissue CD14<sup>+</sup>CD8<sup>+</sup> T cells reprogrammed by myeloid cells and modulated by LPSLaura J Pallett, Leo Swadling, Mariana Diniz, et al.
Pageof 14